Tower Research Capital (TRC)’s Inspire Veterinary Partners IVP Stock Holding History

Tower Research Capital (TRC)’s Portfolio IVP Stock Details IVP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,435	Closed	-$211	–	5338
2025 Q4	$211	Buy	4,435 +1,037	+31%	+$522	﹤0.01%	4993
2025 Q3	$3.33K	Buy	3,398 +678	+25%	+$620	﹤0.01%	4521
2025 Q2	$4.6K	Buy	2,720 +554	+26%	+$878	﹤0.01%	4294
2025 Q1	$3.7K	Buy	2,166 +1,517	+234%	+$3.95K	﹤0.01%	4365
2024 Q4	$3.12K	Buy	649 +488	+303%	+$2.93K	﹤0.01%	4714
2024 Q3	$1.29K	Buy	161 +103	+178%	+$10.4K	﹤0.01%	5180
2024 Q2	$2.3K	Buy	58 +57	+5,700%	+$4.62K	﹤0.01%	5028
2024 Q1	$120	Buy	+1	New	+$317	﹤0.01%	5633
2023 Q4	–	Hold	0	–	–	–	5741
2023 Q3	–	Hold	0	–	–	–	5659

Other funds holding IVP

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Tower Research Capital (TRC)'s IVP Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of Inspire Veterinary Partners (IVP) in Q1 2026, closing a stake of 4,435 shares — an estimated $211 sold.

Tower Research Capital (TRC) first reported a position in IVP in Q1 2024 and held it in 8 quarters. The position peaked at $4.6K in Q2 2025. 2 funds tracked by Wall St. Rank hold IVP as of Q1 2026.

Tower Research Capital (TRC) reported no remaining Inspire Veterinary Partners position as of Q1 2026 after selling out during the quarter.
Tower Research Capital (TRC) sold 4,435 Inspire Veterinary Partners shares in Q1 2026, an estimated $211.
Tower Research Capital (TRC) first reported a position in Inspire Veterinary Partners in Q1 2024 and held it in 8 quarters.
Tower Research Capital (TRC)'s Inspire Veterinary Partners position peaked at $4.6K in Q2 2025.
2 funds tracked by Wall St. Rank held Inspire Veterinary Partners as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.